Drug-labels.com

Mylan-Exemestane: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
25 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Mylan-Exemestane

ABOUT THIS MEDICATION

What the medication is used for:

Mylan-Exemestane is used for the adjuvant treatment of early breast cancer in postmenopausal women who had been treated previously with tamoxifen for 2 to 3 years.

Mylan-Exemestane is also used to treat advanced breast cancer in postmenopausal women who had been treated previously with antiestrogens (for example, tamoxifen).

Adjuvant means “in addition to”. In early breast cancer, this means that additional treatment is required after primary treatment. The reason for this is that after surgery, a small number of cancer cells may remain in the body. These cells can continue to multiply and spread. Adjuvant therapy is given to prevent or delay these cells from multiplying and spreading. Cytotoxic chemotherapy, radiation, and hormonal treatment are three common forms of adjuvant treatment.

What it does:

Mylan-Exemestane interferes with a substance called aromatase which is needed to make the female sex hormone, estrogen, especially in postmenopausal women. Mylan-Exemestane reduces the amount of estrogen in the body. This is helpful because estrogen may influence the growth of certain types of breast cancer cells.

When the medication should not be used:

If you are allergic to exemestane or any other ingredient in Mylan-Exemestane tablets.

What the medicinal ingredient is:

The active ingredient is exemestane.

What the nonmedicinal ingredients are:

Butylated hydroxyanisole, butylated hydroxytoluene, colloidal silicon dioxide, crospovidone, ethyl alcohol, hypromellose, lactose monohydrate, magnesium carbonate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium bicarbonate, sodium lauryl sulfate, sodium starch glycolate, titanium dioxide, and triacetin.

What dosage forms it comes in:

Mylan-Exemestane is available in tablets. Each tablet contains 25 mg of exemestane. The tablets are white, film-coated, round and biconvex.

WARNINGS AND PRECAUTIONS

GS AND PRECAUTIONS

Serious Warnings and Precautions

Mylan-Exemestane is not recommended in pre-menopausal women as safety and efficacy have not been established in this group of patients.

The use of estrogen lowering agents, including Mylan-Exemestane, may cause bone loss. Women with osteoporosis (brittle bones), or at high risk of osteoporosis should be carefully monitored by their doctor. These women may require treatment for osteoporosis or treatment to prevent osteoporosis while receiving Mylan-Exemestane.

Mylan-Exemestane should be administered under the supervision of a qualified physician experienced in the use of anti-cancer agents.

The use of aromatase inhibitors, including Mylan-Exemestane, may increase the risk of ischemic cardiovascular diseases, such as heart attacks and angina. Women at risk of heart disease should be carefully monitored by their doctor.

The use of aromatase inhibitors, including Mylan-Exemestane, may increase the occurrence of high cholesterol. Your physician should continue his/her routine practice of checking lipid and cholesterol levels on a regular basis.

BEFORE you use Mylan-Exemestane talk to your doctor or pharmacist:

  • If you have previously had an allergic reaction to exemestane or any of the other ingredients of Mylan-Exemestane (listed above).
  • If you are still having your period
  • If you are pregnant or likely to be pregnant or breast-feeding.

  • If you are taking Mylan-Exemestane and have been prescribed hormone replacement therapy (HRT) or estrogens, you should discuss this with your doctor.
  • If you have or have had kidney or liver disease
  • If you have or have had cardiovascular or heart disease including any of the following: heart attack, stroke or uncontrolled blood pressure
  • If you have or have had high cholesterol
  • If you have been diagnosed with osteoporosis or have had a bone fracture related to osteoporosis because this medication may cause bone loss.

If you feel drowsy, dizzy or weak while taking Mylan-Exemestane, do not drive or operate machinery.

If you need to go into hospital while taking Mylan-Exemestane, let the doctor know about your medication.

INTERACTIONS WITH THIS MEDICATION

If you are taking tamoxifen and warfarin and switch to exemestane, your warfarin dose may need to be adjusted.

Taking other medications:

Mylan-Exemestane and other medication may affect each other. Inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed by a doctor, including non-prescription drugs or herbal medicines. During treatment do not start taking any new medicine without checking first with your doctor or pharmacist.

PROPER USE OF THIS MEDICATION

Usual dose:

Your doctor will discuss with you how long you will take

Mylan-Exemestane.

The recommended dose is one 25 mg tablet, once daily, by mouth. The tablet should be taken with food (preferably after a meal). Try to take your tablet at the same time each day.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

If too many tablets are taken by accident, contact your doctor at once, go to the nearest hospital or call a local poison control centre.

Missed Dose:

If you forget to take a dose of Mylan-Exemestane, don’t worry; take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and go back to your regular dosage schedule. Do not double dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Mylan-Exemestane, like all other medicines, may cause unwanted effects in some people.

Many women can take Mylan-Exemestane without any problems, but some women may have mild to moderate side effects. If you have any of the following side effects, tell your doctor or pharmacist as soon as possible.

Very common side effects (they affect more than 10 in every 100 patients)

  • Hot flushes
  • Nausea
  • Fatigue
  • Dizziness
  • Pain in bones and joints (arthralgia)
  • Depression
  • Excessive sweating
  • Headache
  • Abdominal pain

Common side effects (they affect between 1 to 10 in every 100 patients)

  • Bone loss (osteoporosis)
  • Bone fractures
  • Sleeplessness
  • Skin rash
  • Increase of appetite
  • Muscle and joint pain
  • Constipation
  • Weight gain
  • Hair loss
  • Diarrhea
  • Excess fluid usually in the legs
  • Indigestion
  • High blood pressure
  • High cholesterol
  • Pain or burning sensation in the hands or wrists (carpal tunnel syndrome)
  • Hives
  • Itchiness
  • Infections of the urinary tract
  • Abnormal liver function test results (blood test disorders)

Uncommon side effects (they affect between 1 to 10 in every 1000 patients)

  • Hypersensitivity (including anaphylactic reaction)
  • Burning stomach pain, heart burn, nausea or vomiting that could progress to blood in stools, black tarry stools or vomiting of blood (gastric ulcers)
  • Nerve damage with symptoms such as such as pain, burning, or numbness (neuropathy)
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN
AND WHAT TO DO ABOUT THEM
Symptom /effectTalk with your doctor or pharmacistStop taking drug and seek immediate emergency medical attention
Only if severeIn all cases
Common
Pain in muscles, bones and joints√
Vaginal Bleeding√
Uncommon
Chest Pain in association with shortness of breath and sensation of fullness/ heaviness√√
Burning stomach pain, heart burn, nausea or vomiting that could progress to blood in stools, black tarry stools or vomiting of blood (gastric ulcer)√√
Hypersensitivity (including anaphylactic reactions)√√
Rare
Allergic Reaction (skin rash/ swelling/difficulty breathing)√
Yellowing of the skin or eyes, nausea, loss of appetite, dark-coloured urine (signs of hepatitis)√√

This is not a complete list of side effects. For any unexpected effects while taking Mylan-Exemestane, contact your doctor or pharmacist.

HOW TO STORE IT

  • Keep them in the original package and store them at 15-30°C. Avoid places where the temperature may rise above 30°C.
  • Keep this medicine out of the reach of children.

    • Before use, check the expiry date printed on the pack. Do not use after this date. Remember to take any unused medication back to your pharmacist.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at

www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document can be found at: www.mylan.ca.

The full Product Monograph prepared for health professionals can be obtained by contacting the sponsor, Mylan Pharmaceuticals ULC at: 1-800-575-1379

Etobicoke, Ontario M8Z 2S6

Last revised: May 20, 2014

Mylan Pharmaceuticals ULC

Etobicoke, ON M8Z 2S6

1-800-575-1379

www.mylan.ca

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02405075

Revision date stated in the text: May 20, 2014

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mylan-Exemestane

Rx or OTC
Prescription (Rx)?
DIN 02405075
Schedule(s) PRESCRIPTION
Active ingredient(s) Exemestane 25 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L02 Endocrine therapy antineoplastic and immunomodulating agents
      1. L02B Hormone antagonists and related agents
        1. L02BG Aromatase inhibitors
          1. L02BG06 Exemestane
Company MYLAN PHARMACEUTICALS ULC
Current status Cancelled Pre Market
Current status date November 2, 2016

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.